Published in J Clin Apher on January 01, 1991
PhosphoBase, a database of phosphorylation sites: release 2.0. Nucleic Acids Res (1999) 2.61
The application of hematopoietic growth factors in drug-induced agranulocytosis: a review of 70 cases. Leukemia (1994) 2.26
Prediction of human protein function from post-translational modifications and localization features. J Mol Biol (2002) 2.05
Statistical analysis of protein kinase specificity determinants. FEBS Lett (1998) 1.53
Product binding and role of the C-terminal region in class I D-fructose 1,6-bisphosphate aldolase. Nat Struct Biol (1997) 1.42
Autologous stem cell transplantation in multiple myeloma after VAD and EDAP courses: a high incidence of oligoclonal serum Igs post transplantation. Bone Marrow Transplant (2000) 1.42
CD34+/CD36- cells from myelodysplasia patients have a limited capacity to proliferate but can differentiate in response to Epo and MGF stimulation. Leukemia (1998) 1.39
Successful immunosuppressive treatment after failure of erythropoietin therapy in two subjects with refractory anaemia. Br J Haematol (1993) 1.38
[Hematopoietic growth factors as supportive treatment in drug-induced agranulocytosis]. Ned Tijdschr Geneeskd (1993) 1.38
Reduced transfusion requirements by recombinant factor VIIa in orthotopic liver transplantation: a pilot study. Transplantation (2001) 1.25
Cytotoxicity of apigenin on leukemia cell lines: implications for prevention and therapy. Cell Death Dis (2010) 1.13
Platelet kinetic studies in patients with idiopathic thrombocytopenic purpura. Am J Med (1999) 0.95
Ultrastructural analysis of circulating cytomegalic cells in patients with active cytomegalovirus infection: evidence for virus production and endothelial origin. J Infect Dis (1993) 0.95
A case of localized Castleman's disease with systemic involvement: treatment and pathogenetic aspects. Ann Hematol (1996) 0.95
In vivo protection of nigral dopamine neurons by lentiviral gene transfer of the novel GDNF-family member neublastin/artemin. Mol Cell Neurosci (2000) 0.94
Validation of the determination of deltaF508 mutations of the cystic fibrosis gene in over 11 000 mouthwashes. Hum Genet (1996) 0.91
Blood loss in orthotopic liver transplantation: a retrospective analysis of transfusion requirements and the effects of autotransfusion of cell saver blood in 164 consecutive patients. Blood Coagul Fibrinolysis (2000) 0.90
Absence of seroconversion for HTLV-III in haemophiliacs intensively treated with heat treated factor VIII concentrate. Br Med J (Clin Res Ed) (1986) 0.90
Consolidation therapy with autologous stem cell transplantation in plasma cell leukemia after VAD, high-dose cyclophosphamide and EDAP courses: a report of three cases and a review of the literature. Bone Marrow Transplant (1997) 0.88
99mTc-MIBI myocardial perfusion imaging in myocarditis. Nucl Med Commun (2003) 0.86
Ultrastructural morphology and localisation of cisplatin-induced platinum-DNA adducts in a cisplatin-sensitive and -resistant human small cell lung cancer cell line using electron microscopy. Biochem Pharmacol (2001) 0.86
Initial events in radiation-induced atheromatosis. II. Damage to intimal cells. Strahlentherapie (1978) 0.86
Interleukin-4 and its receptor; modulating effects on immature and mature hematopoietic cells. Leukemia (1993) 0.85
Replacement fluid in plasma exchange. Lancet (1980) 0.84
Intensive chemotherapy with autologous bone marrow transfusion as primary treatment in women with breast cancer and more than five involved axillary lymph nodes. Eur J Cancer (1994) 0.83
Interferon-gamma modulates the lipopolysaccharide-induced expression of AP-1 and NF-kappa B at the mRNA and protein level in human monocytes. Exp Hematol (1996) 0.82
High-yield method of production of freeze-dried purified factor VIII by blood banks. Lancet (1981) 0.82
Comparison of apheresis and other methods for separation and purification of hemopoietic stem cells: initial experience with a blood buffy coat model for the use of autologous bone marrow transplantation. Int J Artif Organs (1984) 0.81
Uptake of pp65 in in vitro generated pp65-positive polymorphonuclear cells mediated by phagocytosis and cell fusion? Intervirology (2001) 0.81
Circulating cytomegalovirus-infected endothelial cells after renal transplantation: possible clue to pathophysiology? Transplant Proc (1995) 0.81
Recombinant human erythropoietin in patients with myelodysplastic syndromes. Leukemia (1991) 0.80
Mitochondrial disruption and limited apoptosis of erythroblasts are associated with high risk myelodysplasia. An ultrastructural analysis. Leuk Res (2001) 0.80
A prospective, randomized, double-blinded, placebo-controlled trial of empirical teicoplanin in febrile neutropenia with persistent fever after imipenem monotherapy. J Antimicrob Chemother (2000) 0.79
Hematologic aspects of cardiotomy suction in cardiac operations. J Thorac Cardiovasc Surg (1980) 0.79
Abruptio placentae, disseminated intravascular coagulation and the use of heparin: a must? Bibl Anat (1973) 0.79
Heparin and factor VIII. Scand J Haematol Suppl (1984) 0.79
The lower third molar and antiphlogistics. Int J Oral Surg (1982) 0.79
Saponin, an inhibitory agent of carbon dioxide production by white cells: its use in the microbiologic examination of blood components in an automated bacterial culture system. Transfusion (1998) 0.79
Haemovigilance systems. Vox Sang (1999) 0.78
Small-pool high-yield factor VIII production. Crit Rev Clin Lab Sci (1986) 0.78
Long-term treatment with interferon-alpha 2b for severe pruritus in patients with polycythaemia vera. Br J Haematol (1995) 0.78
In polycythemia vera human interleukin 3 and granulocyte-macrophage colony-stimulating factor enhance erythroid colony growth in the absence of erythropoietin. Exp Hematol (1989) 0.78
Prevention of vessel wall damage in experimental irradiation. Bibl Anat (1973) 0.77
Improved hemocompatibility in open heart surgery. Trans Am Soc Artif Intern Organs (1978) 0.77
Prevalence of delta F508 cystic fibrosis carriers in The Netherlands: logistic regression on sex, age, region of residence and number of offspring. Hum Genet (1997) 0.77
Abnormal platelet adhesion on abdominal vessels in asymptomatic patients with paroxysmal nocturnal hemoglobinuria. Ann Hematol (2001) 0.77
Correction of neutropenia by GM-CSF in patients with a large granular lymphocyte proliferation. Ann Hematol (1992) 0.77
Sulfasalazine induced agranulocytosis treated with granulocyte-macrophage colony stimulating factor. J Rheumatol (1992) 0.77
Clonal chronic lymphocytic leukaemia-like B lymphocytes in the blood of patients with cutaneous T-cell disorders. Br J Haematol (1993) 0.76
In vitro evaluation of a high-efficiency leukocyte adherence filter. Ann Hematol (1991) 0.76
Alpha-interferon for intractable pruritus in polycythaemia vera. Lancet (1991) 0.76
Effects of prednisone and splenectomy in patients with idiopathic thrombocytopenic purpura: only splenectomy induces a complete remission. Ann Hematol (2001) 0.76
Risk of transmission of human immunodeficiency virus (HIV) by heat-treated factor VIII concentrates in patients with severe hemophilia A. Transfusion (1987) 0.76
Gelatin particle agglutination assay as an auxiliary confirmation test for HIV-1 antibodies. Med Lab Sci (1990) 0.75
The role of blood microfilters in clinical practice. Intensive Care Med (1993) 0.75
A simplified method for purification, concentration and freezing of bone marrow cells for autologous transplantation. Int J Artif Organs (1990) 0.75
Metabolic aspects and viability of heparin/CPDA-1-stored red cell concentrate as a by-product of a high-yield factor VIII production method. Haemostasis (1983) 0.75
Interleukin-4 prevents the induction of G-CSF mRNA in human adherent monocytes in response to endotoxin and IL-1 stimulation. Br J Haematol (1991) 0.75
Is mortality rate what it is all about in congestive heart failure? Lancet (1995) 0.75
Plasma-exchange program in a regional blood bank with a reference to Guillain-Barré syndrome. Ric Clin Lab (1983) 0.75
Recombinant human mast cell growth factor supports erythroid colony formation in polycythemia vera in the presence and absence of erythropoietin and serum. Exp Hematol (1993) 0.75
Characterization of the erythropoiesis in myelodysplasia by means of ferrokinetic studies, in vitro erythroid colony formation and soluble transferrin receptor. Leukemia (1998) 0.75
Combined HIV-1/2 assay kits. Lancet (1991) 0.75
[The use of blood and blood products in total hip arthroplasty in 31 European hospitals, 1990/'91]. Ned Tijdschr Geneeskd (1996) 0.75
[Epistaxis caused by an acquired thrombocytopathy]. Ned Tijdschr Geneeskd (1989) 0.75
The effect of cyclosporine on haematological parameters in patients with paroxysmal nocturnal haemoglobinuria. Br J Haematol (1995) 0.75
Autologous cryopreserved platelets and prophylaxis of bleeding in autologous bone marrow transplantation. Blut (1983) 0.75
Ischaemic colitis and lung infiltrates caused by extramedullary haematopoiesis in a patient with an acute erythroid leukaemia following polycythaemia vera. Neth J Med (1998) 0.75
Severe bleeding caused by an inhibitor to coagulation factor V: a case report. Blood Coagul Fibrinolysis (1994) 0.75
Recombinant erythropoietin failed to correct anemia in Fanconi syndrome. Leukemia (1989) 0.75
Pyridoxin-responsive anaemia in a patient with a history of polycythaemia vera. J Intern Med (1997) 0.75
Blood components for developing countries. Lancet (1981) 0.75
Western blotting for HIV-antibody confirmation in blood donors: an improved approach by recombinant immunoblots. Transfus Med (1992) 0.75
Informing blood donors about AIDS and risk factors: reactions to information provided in a regional blood bank in the Netherlands. AIDS (1989) 0.75
Heparin small pool high yield purified factor VIII: in vivo recovery and half-life of routinely produced freeze-dried concentrate. Thromb Haemost (1984) 0.75
Evaluation of elutriated single donor platelets collected and stored in a closed system. J Clin Apher (1992) 0.75
Polyclonal expansion of T-cell receptor-gamma delta+ T lymphocytes associated with neutropenia and thrombocytopenia. Leukemia (1992) 0.75
[Personal responsibility of the blood donor for the safety of blood transfusion]. Ned Tijdschr Geneeskd (1989) 0.75
Bleeding prophylaxis in autologous bone marrow transplantation for solid tumors. Comparison of cryopreserved autologous and fresh allogeneic single-donor platelets. Haemostasis (1989) 0.75
[Subspecialty blood transfusion medicine]. Ned Tijdschr Geneeskd (1998) 0.75
High-dosage chemotherapy with autologous bone marrow reinfusion in the treatment of patients with solid tumours. The Groningen experience, 1981-1986. Neth J Med (1986) 0.75
Application of computers in blood transfusion. Baillieres Clin Haematol (1990) 0.75
Partial tetrasomy of 9P: a rare chromosomal abnormality in polycythaemia vera. Br J Haematol (2001) 0.75
Alpha- and gamma-tocopherol in plasma, red blood cells, and platelets during plasma exchange. J Clin Apher (1990) 0.75
[Prevention of immunization against erythrocyte antigens c, E and K caused by blood transfusions]. Ned Tijdschr Geneeskd (1994) 0.75
Worldwide overview of plasma procurement and fractionation. Scand J Haematol Suppl (1984) 0.75
Stabilization of standard platelet concentrates and minimization of the platelet storage lesion by a prostacyclin analogue. Ann Hematol (1992) 0.75
Effects of peripheral stem cell or bone marrow reinfusion on peripheral serotonin metabolism. Bone Marrow Transplant (1999) 0.75
Plasma exchange in five patients with acute Guillain Barré syndrome. Int J Artif Organs (1981) 0.75
Killing capacity of LAK cell transduced lymphocytes harvested by Haemonetics V50 lymphosurge technique. Prog Clin Biol Res (1990) 0.75
Complications of therapeutic plasma exchange. Lancet (1983) 0.75
Factor VIII:C assay: influence of buffer components used in immunoaffinity chromatography for purification of factor VIII/von Willebrand factor. Thromb Res (1994) 0.75
Effective treatment of severe bleeding due to acquired thrombocytopathia by single dose administration of activated recombinant factor VII. Thromb Haemost (1998) 0.75